CTI BioPharma

+$0.15 (+2.90%) Today
+$0.03 (+0.56%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTI BioPharma and other ETFs, options, and stocks.

About CTIC

CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis.

CEO
Adam R. Craig
Employees
121
Headquarters
Seattle, Washington
Founded
1991

CTIC Key Statistics

Market cap
579.70M
Price-Earnings ratio
—
Dividend yield
—
Average volume
3.72M
High today
$5.42
Low today
$5.07
Open price
$5.16
Volume
3.37M
52 Week high
$5.76
52 Week low
$1.43

CTIC Earnings

-$0.41
-$0.27
-$0.14
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.41 per share
Actual
-$0.37 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure